We came across a bullish thesis on Amgen Inc. on R. Dennis’s Substack by OppCost. In this article, we will summarize the bulls’ thesis on AMGN. Amgen Inc.’s share was trading at $382.87 as of February 24th. AMGN’s trailing and forward P/E were 24.32 and 13.74, respectively according to Yahoo Finance.
Elena Pavlovich/Shutterstock.com
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. AMGN is attracting bullish positioning after a trader sold...
